These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 20131059)
1. Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing. Felsberg J; Wolter M; Seul H; Friedensdorf B; Göppert M; Sabel MC; Reifenberger G Acta Neuropathol; 2010 Apr; 119(4):501-7. PubMed ID: 20131059 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic algorithm for pathological evaluation of gliomas in a resource-constrained setting. Jain S; Gupta P; Shankar KB; Singh R; Siraj F J Cancer Res Ther; 2023; 19(3):562-566. PubMed ID: 37470575 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the IDH1 codon 132 mutation in brain tumors. Balss J; Meyer J; Mueller W; Korshunov A; Hartmann C; von Deimling A Acta Neuropathol; 2008 Dec; 116(6):597-602. PubMed ID: 18985363 [TBL] [Abstract][Full Text] [Related]
4. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Reuss DE; Sahm F; Schrimpf D; Wiestler B; Capper D; Koelsche C; Schweizer L; Korshunov A; Jones DT; Hovestadt V; Mittelbronn M; Schittenhelm J; Herold-Mende C; Unterberg A; Platten M; Weller M; Wick W; Pfister SM; von Deimling A Acta Neuropathol; 2015 Jan; 129(1):133-46. PubMed ID: 25427834 [TBL] [Abstract][Full Text] [Related]
5. [Prognostic significance of combined TERT and IDH gene mutation analysis in diffusely infiltrating gliomas]. Liu QQ; Yin XX; Zou Y; Yu TP; Gong J; Chen XQ; Nie L; Xu M; Zhang MN; Zhou Q; Chen N Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):658-663. PubMed ID: 30220117 [No Abstract] [Full Text] [Related]
7. IDH1 and IDH2 mutations in gliomas. Yan H; Parsons DW; Jin G; McLendon R; Rasheed BA; Yuan W; Kos I; Batinic-Haberle I; Jones S; Riggins GJ; Friedman H; Friedman A; Reardon D; Herndon J; Kinzler KW; Velculescu VE; Vogelstein B; Bigner DD N Engl J Med; 2009 Feb; 360(8):765-73. PubMed ID: 19228619 [TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of IDH1 in paired gliomas revealed IDH1 mutation was not associated with malignant progression but predicted longer survival. Yao Y; Chan AK; Qin ZY; Chen LC; Zhang X; Pang JC; Li HM; Wang Y; Mao Y; Ng HK; Zhou LF PLoS One; 2013; 8(6):e67421. PubMed ID: 23840696 [TBL] [Abstract][Full Text] [Related]
9. IDH1/2 gene hotspot mutations in central nervous system tumours: analysis of 922 Chinese patients. Chen N; Yu T; Gong J; Nie L; Chen X; Zhang M; Xu M; Tan J; Su Z; Zhong J; Zhou Q Pathology; 2016 Dec; 48(7):675-683. PubMed ID: 27780605 [TBL] [Abstract][Full Text] [Related]
10. Estimation of the occurrence rates of Cho U; Yang SH; Yoo C J Int Med Res; 2021 Jun; 49(6):3000605211019258. PubMed ID: 34162262 [TBL] [Abstract][Full Text] [Related]
11. Pyrosequencing of IDH1 and IDH2 mutations in brain tumors and non-neoplastic conditions. Cykowski MD; Allen RA; Fung KM; Harmon MA; Dunn ST Diagn Mol Pathol; 2012 Dec; 21(4):214-20. PubMed ID: 23111198 [TBL] [Abstract][Full Text] [Related]
12. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337 [TBL] [Abstract][Full Text] [Related]
13. [Mutation of isocitrate dehydrogenase gene in Chinese patients with glioma]. Pan Y; Qi XL; Wang LM; Dong RF; Zhang M; Zheng DF; Chang Q; Zhong YF Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):292-8. PubMed ID: 24004584 [TBL] [Abstract][Full Text] [Related]
14. Analysis of NADP+-dependent isocitrate dehydrogenase-1/2 gene mutations in pediatric brain tumors: report of a secondary anaplastic astrocytoma carrying the IDH1 mutation. Mascelli S; Raso A; Biassoni R; Severino M; Sak K; Joost K; Milanaccio C; Barra S; Grillo-Ruggieri F; Vanni I; Consales A; Cama A; Capra V; Nozza P; Garrè ML J Neurooncol; 2012 Sep; 109(3):477-84. PubMed ID: 22821382 [TBL] [Abstract][Full Text] [Related]
15. Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation status. Ohno M; Narita Y; Miyakita Y; Okita Y; Matsushita Y; Yoshida A; Fukushima S; Ichimura K; Kayama T; Shibui S Brain Tumor Pathol; 2012 Oct; 29(4):183-91. PubMed ID: 22790483 [TBL] [Abstract][Full Text] [Related]
16. MGMT CpG island is invariably methylated in adult astrocytic and oligodendroglial tumors with IDH1 or IDH2 mutations. Mulholland S; Pearson DM; Hamoudi RA; Malley DS; Smith CM; Weaver JM; Jones DT; Kocialkowski S; Bäcklund LM; Collins VP; Ichimura K Int J Cancer; 2012 Sep; 131(5):1104-13. PubMed ID: 22020830 [TBL] [Abstract][Full Text] [Related]
17. IDH1 mutation in pediatric gliomas: has it a diagnostic and prognostic value? Buccoliero AM; Castiglione F; Degl'Innocenti DR; Gheri CF; Genitori L; Taddei GL Fetal Pediatr Pathol; 2012 Oct; 31(5):278-82. PubMed ID: 22432788 [TBL] [Abstract][Full Text] [Related]
18. Pathologic diversity of glioneuronal tumor with neuropil-like islands: a histological and immunohistochemical study with a special reference to isocitrate dehydrogenase 1 (IDH1) in 5 cases. Ishizawa K; Hirose T; Sugiyama K; Kageji T; Nobusawa S; Homma T; Komori T; Sasaki A Clin Neuropathol; 2012; 31(2):67-76. PubMed ID: 22385787 [TBL] [Abstract][Full Text] [Related]
19. Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas. Cryan JB; Haidar S; Ramkissoon LA; Bi WL; Knoff DS; Schultz N; Abedalthagafi M; Brown L; Wen PY; Reardon DA; Dunn IF; Folkerth RD; Santagata S; Lindeman NI; Ligon AH; Beroukhim R; Hornick JL; Alexander BM; Ligon KL; Ramkissoon SH Oncotarget; 2014 Sep; 5(18):8083-92. PubMed ID: 25257301 [TBL] [Abstract][Full Text] [Related]
20. IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom. Stockhammer F; Misch M; Helms HJ; Lengler U; Prall F; von Deimling A; Hartmann C Seizure; 2012 Apr; 21(3):194-7. PubMed ID: 22217666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]